Dopamine receptor D4
Dopamine Receptor D4[edit | edit source]
The dopamine receptor D4 (DRD4) is a G protein-coupled receptor that is encoded by the DRD4 gene in humans. It is one of the five types of dopamine receptors, which are responsible for the physiological effects of the neurotransmitter dopamine. The D4 receptor is of particular interest due to its role in the modulation of cognition, emotion, and behavior.
Structure[edit | edit source]
The D4 receptor is a member of the D2-like receptor family, which also includes the dopamine receptor D2 and dopamine receptor D3. These receptors are characterized by their ability to inhibit the enzyme adenylyl cyclase through the activation of Gi/o proteins. The D4 receptor has a high degree of polymorphism, particularly in the third intracellular loop, which may influence its function and expression.
Function[edit | edit source]
D4 receptors are primarily found in the frontal cortex, amygdala, hypothalamus, and hippocampus. They play a crucial role in modulating synaptic transmission and are involved in the regulation of mood, attention, and reward. The D4 receptor has been implicated in various neuropsychiatric disorders, including schizophrenia, bipolar disorder, and attention deficit hyperactivity disorder (ADHD).
Ligands[edit | edit source]
D4 receptors can be targeted by various ligands, which can act as either agonists or antagonists. Agonists such as apomorphine and dopamine itself activate the receptor, while antagonists like clozapine and haloperidol inhibit its activity. The development of selective D4 receptor ligands is an area of active research, with potential therapeutic applications in treating psychiatric disorders.
Clinical Significance[edit | edit source]
The D4 receptor has been studied extensively in the context of pharmacogenetics, as variations in the DRD4 gene have been associated with differences in drug response and susceptibility to certain disorders. For example, the 7-repeat allele of the DRD4 gene has been linked to an increased risk of ADHD and novelty seeking behavior.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
